Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma

NCT01145170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Intrinsic Brainstem Gliomas

Interventions

RADIATION: Radiotherapy
BIOLOGICAL: Nimotuzumab

Sponsor

Eurofarma Laboratorios S.A.

Collaborators

[object Object]